nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorouracil—CYP2C8—Spironolactone—dilated cardiomyopathy	0.157	0.531	CbGbCtD
Fluorouracil—ALB—Furosemide—dilated cardiomyopathy	0.139	0.469	CbGbCtD
Fluorouracil—CYP2C9—cardial valve—dilated cardiomyopathy	0.04	0.207	CbGeAlD
Fluorouracil—Pemphigoid—Furosemide—dilated cardiomyopathy	0.0383	0.105	CcSEcCtD
Fluorouracil—Gastrointestinal symptom NOS—Spironolactone—dilated cardiomyopathy	0.015	0.0414	CcSEcCtD
Fluorouracil—DPYD—myocardium—dilated cardiomyopathy	0.0146	0.0755	CbGeAlD
Fluorouracil—Common cold—Lisinopril—dilated cardiomyopathy	0.0138	0.038	CcSEcCtD
Fluorouracil—UMPS—heart—dilated cardiomyopathy	0.0137	0.0708	CbGeAlD
Fluorouracil—UPP1—heart—dilated cardiomyopathy	0.0126	0.0649	CbGeAlD
Fluorouracil—Application site pain—Furosemide—dilated cardiomyopathy	0.0109	0.0301	CcSEcCtD
Fluorouracil—UPP1—cardiac atrium—dilated cardiomyopathy	0.0107	0.0555	CbGeAlD
Fluorouracil—DPYD—heart—dilated cardiomyopathy	0.0102	0.0527	CbGeAlD
Fluorouracil—Ulcer—Spironolactone—dilated cardiomyopathy	0.00934	0.0257	CcSEcCtD
Fluorouracil—TYMP—cardiac ventricle—dilated cardiomyopathy	0.009	0.0465	CbGeAlD
Fluorouracil—DPYD—cardiac atrium—dilated cardiomyopathy	0.00872	0.0451	CbGeAlD
Fluorouracil—Local reaction—Furosemide—dilated cardiomyopathy	0.00868	0.0239	CcSEcCtD
Fluorouracil—Dysaesthesia—Lisinopril—dilated cardiomyopathy	0.00833	0.023	CcSEcCtD
Fluorouracil—ABCC5—cardiac ventricle—dilated cardiomyopathy	0.00754	0.039	CbGeAlD
Fluorouracil—ABCC5—myocardium—dilated cardiomyopathy	0.00709	0.0367	CbGeAlD
Fluorouracil—SLC29A1—cardiac ventricle—dilated cardiomyopathy	0.00692	0.0358	CbGeAlD
Fluorouracil—Blister—Furosemide—dilated cardiomyopathy	0.00666	0.0184	CcSEcCtD
Fluorouracil—Lethargy—Spironolactone—dilated cardiomyopathy	0.00654	0.018	CcSEcCtD
Fluorouracil—SLC29A1—myocardium—dilated cardiomyopathy	0.00651	0.0337	CbGeAlD
Fluorouracil—Ataxia—Spironolactone—dilated cardiomyopathy	0.00603	0.0166	CcSEcCtD
Fluorouracil—TYMP—heart—dilated cardiomyopathy	0.00591	0.0306	CbGeAlD
Fluorouracil—MTHFR—heart—dilated cardiomyopathy	0.00555	0.0287	CbGeAlD
Fluorouracil—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00548	0.0151	CcSEcCtD
Fluorouracil—Heartburn—Lisinopril—dilated cardiomyopathy	0.00524	0.0144	CcSEcCtD
Fluorouracil—TYMP—cardiac atrium—dilated cardiomyopathy	0.00505	0.0261	CbGeAlD
Fluorouracil—ABCC5—heart—dilated cardiomyopathy	0.00495	0.0256	CbGeAlD
Fluorouracil—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00461	0.0127	CcSEcCtD
Fluorouracil—SLC29A1—heart—dilated cardiomyopathy	0.00454	0.0235	CbGeAlD
Fluorouracil—ABCC5—cardiac atrium—dilated cardiomyopathy	0.00423	0.0219	CbGeAlD
Fluorouracil—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00403	0.0111	CcSEcCtD
Fluorouracil—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00397	0.0109	CcSEcCtD
Fluorouracil—Swelling—Furosemide—dilated cardiomyopathy	0.00395	0.0109	CcSEcCtD
Fluorouracil—Alopecia—Spironolactone—dilated cardiomyopathy	0.00392	0.0108	CcSEcCtD
Fluorouracil—SLC29A1—cardiac atrium—dilated cardiomyopathy	0.00389	0.0201	CbGeAlD
Fluorouracil—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00384	0.0106	CcSEcCtD
Fluorouracil—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00365	0.01	CcSEcCtD
Fluorouracil—Lethargy—Furosemide—dilated cardiomyopathy	0.00356	0.0098	CcSEcCtD
Fluorouracil—ALB—heart—dilated cardiomyopathy	0.00354	0.0183	CbGeAlD
Fluorouracil—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00346	0.00951	CcSEcCtD
Fluorouracil—ABCC4—heart—dilated cardiomyopathy	0.00343	0.0177	CbGeAlD
Fluorouracil—Photophobia—Lisinopril—dilated cardiomyopathy	0.00338	0.00932	CcSEcCtD
Fluorouracil—Irritability—Furosemide—dilated cardiomyopathy	0.00333	0.00917	CcSEcCtD
Fluorouracil—Discomfort—Spironolactone—dilated cardiomyopathy	0.00325	0.00894	CcSEcCtD
Fluorouracil—Confusional state—Spironolactone—dilated cardiomyopathy	0.00318	0.00875	CcSEcCtD
Fluorouracil—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00315	0.00868	CcSEcCtD
Fluorouracil—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00308	0.00849	CcSEcCtD
Fluorouracil—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00308	0.00847	CcSEcCtD
Fluorouracil—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00298	0.00822	CcSEcCtD
Fluorouracil—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00298	0.00821	CcSEcCtD
Fluorouracil—Somnolence—Spironolactone—dilated cardiomyopathy	0.0028	0.00771	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00275	0.00758	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00272	0.00749	CcSEcCtD
Fluorouracil—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00262	0.00721	CcSEcCtD
Fluorouracil—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.0026	0.00715	CcSEcCtD
Fluorouracil—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00251	0.00691	CcSEcCtD
Fluorouracil—Urticaria—Spironolactone—dilated cardiomyopathy	0.0025	0.00689	CcSEcCtD
Fluorouracil—Irritability—Lisinopril—dilated cardiomyopathy	0.0025	0.00688	CcSEcCtD
Fluorouracil—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00249	0.00686	CcSEcCtD
Fluorouracil—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00249	0.00685	CcSEcCtD
Fluorouracil—Ataxia—Lisinopril—dilated cardiomyopathy	0.00246	0.00677	CcSEcCtD
Fluorouracil—ABCG2—heart—dilated cardiomyopathy	0.00242	0.0125	CbGeAlD
Fluorouracil—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00234	0.00644	CcSEcCtD
Fluorouracil—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00232	0.00639	CcSEcCtD
Fluorouracil—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00224	0.00617	CcSEcCtD
Fluorouracil—Pruritus—Spironolactone—dilated cardiomyopathy	0.00223	0.00614	CcSEcCtD
Fluorouracil—CYP2C9—heart—dilated cardiomyopathy	0.00221	0.0114	CbGeAlD
Fluorouracil—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.0022	0.00607	CcSEcCtD
Fluorouracil—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00216	0.00594	CcSEcCtD
Fluorouracil—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00216	0.00593	CcSEcCtD
Fluorouracil—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00215	0.00591	CcSEcCtD
Fluorouracil—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.0021	0.00579	CcSEcCtD
Fluorouracil—Erythema—Furosemide—dilated cardiomyopathy	0.0021	0.00578	CcSEcCtD
Fluorouracil—Dizziness—Spironolactone—dilated cardiomyopathy	0.00208	0.00574	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00206	0.00568	CcSEcCtD
Fluorouracil—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00203	0.00558	CcSEcCtD
Fluorouracil—Vomiting—Spironolactone—dilated cardiomyopathy	0.002	0.00552	CcSEcCtD
Fluorouracil—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00199	0.00547	CcSEcCtD
Fluorouracil—Rash—Spironolactone—dilated cardiomyopathy	0.00199	0.00547	CcSEcCtD
Fluorouracil—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00198	0.00546	CcSEcCtD
Fluorouracil—Vision blurred—Furosemide—dilated cardiomyopathy	0.00198	0.00545	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00198	0.00544	CcSEcCtD
Fluorouracil—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00198	0.00544	CcSEcCtD
Fluorouracil—Headache—Spironolactone—dilated cardiomyopathy	0.00197	0.00543	CcSEcCtD
Fluorouracil—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00196	0.0054	CcSEcCtD
Fluorouracil—Anaemia—Furosemide—dilated cardiomyopathy	0.00194	0.00535	CcSEcCtD
Fluorouracil—Epistaxis—Lisinopril—dilated cardiomyopathy	0.0019	0.00524	CcSEcCtD
Fluorouracil—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00189	0.00521	CcSEcCtD
Fluorouracil—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00188	0.00518	CcSEcCtD
Fluorouracil—Leukopenia—Furosemide—dilated cardiomyopathy	0.00188	0.00518	CcSEcCtD
Fluorouracil—Nausea—Spironolactone—dilated cardiomyopathy	0.00187	0.00515	CcSEcCtD
Fluorouracil—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00181	0.005	CcSEcCtD
Fluorouracil—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.0018	0.00495	CcSEcCtD
Fluorouracil—Confusional state—Furosemide—dilated cardiomyopathy	0.00173	0.00476	CcSEcCtD
Fluorouracil—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00171	0.00472	CcSEcCtD
Fluorouracil—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00168	0.00463	CcSEcCtD
Fluorouracil—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00168	0.00462	CcSEcCtD
Fluorouracil—Anorexia—Furosemide—dilated cardiomyopathy	0.00163	0.0045	CcSEcCtD
Fluorouracil—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00162	0.00445	CcSEcCtD
Fluorouracil—Hypotension—Furosemide—dilated cardiomyopathy	0.0016	0.00441	CcSEcCtD
Fluorouracil—Alopecia—Lisinopril—dilated cardiomyopathy	0.0016	0.0044	CcSEcCtD
Fluorouracil—Erythema—Lisinopril—dilated cardiomyopathy	0.00158	0.00434	CcSEcCtD
Fluorouracil—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00154	0.00424	CcSEcCtD
Fluorouracil—Somnolence—Furosemide—dilated cardiomyopathy	0.00152	0.0042	CcSEcCtD
Fluorouracil—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00149	0.0041	CcSEcCtD
Fluorouracil—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00148	0.00409	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00148	0.00407	CcSEcCtD
Fluorouracil—Pain—Furosemide—dilated cardiomyopathy	0.00147	0.00404	CcSEcCtD
Fluorouracil—Anaemia—Lisinopril—dilated cardiomyopathy	0.00146	0.00401	CcSEcCtD
Fluorouracil—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00141	0.00389	CcSEcCtD
Fluorouracil—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00141	0.00388	CcSEcCtD
Fluorouracil—Urticaria—Furosemide—dilated cardiomyopathy	0.00136	0.00375	CcSEcCtD
Fluorouracil—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00135	0.00373	CcSEcCtD
Fluorouracil—Chest pain—Lisinopril—dilated cardiomyopathy	0.00134	0.00369	CcSEcCtD
Fluorouracil—Myalgia—Lisinopril—dilated cardiomyopathy	0.00134	0.00369	CcSEcCtD
Fluorouracil—UMPS—Metabolism—TAZ—dilated cardiomyopathy	0.00133	0.00902	CbGpPWpGaD
Fluorouracil—Discomfort—Lisinopril—dilated cardiomyopathy	0.00133	0.00365	CcSEcCtD
Fluorouracil—UPP1—Metabolism—ANKRD1—dilated cardiomyopathy	0.00131	0.00892	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—ANKRD1—dilated cardiomyopathy	0.00131	0.00892	CbGpPWpGaD
Fluorouracil—MTHFR—Folate Metabolism—SOD2—dilated cardiomyopathy	0.0013	0.00886	CbGpPWpGaD
Fluorouracil—Confusional state—Lisinopril—dilated cardiomyopathy	0.0013	0.00357	CcSEcCtD
Fluorouracil—Oedema—Lisinopril—dilated cardiomyopathy	0.00129	0.00354	CcSEcCtD
Fluorouracil—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00129	0.00354	CcSEcCtD
Fluorouracil—Infection—Lisinopril—dilated cardiomyopathy	0.00128	0.00352	CcSEcCtD
Fluorouracil—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00126	0.00348	CcSEcCtD
Fluorouracil—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00126	0.00347	CcSEcCtD
Fluorouracil—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00126	0.00346	CcSEcCtD
Fluorouracil—MTHFR—Folate Metabolism—GPX1—dilated cardiomyopathy	0.00124	0.00845	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.00124	0.0084	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—TAZ—dilated cardiomyopathy	0.00124	0.00839	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—TAZ—dilated cardiomyopathy	0.00124	0.00839	CbGpPWpGaD
Fluorouracil—Anorexia—Lisinopril—dilated cardiomyopathy	0.00123	0.00338	CcSEcCtD
Fluorouracil—Pruritus—Furosemide—dilated cardiomyopathy	0.00121	0.00334	CcSEcCtD
Fluorouracil—UMPS—Metabolism—SDHA—dilated cardiomyopathy	0.0012	0.00816	CbGpPWpGaD
Fluorouracil—Hypotension—Lisinopril—dilated cardiomyopathy	0.0012	0.00331	CcSEcCtD
Fluorouracil—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00117	0.00323	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00117	0.00323	CcSEcCtD
Fluorouracil—Insomnia—Lisinopril—dilated cardiomyopathy	0.00116	0.0032	CcSEcCtD
Fluorouracil—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00115	0.00318	CcSEcCtD
Fluorouracil—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00115	0.00316	CcSEcCtD
Fluorouracil—Somnolence—Lisinopril—dilated cardiomyopathy	0.00114	0.00315	CcSEcCtD
Fluorouracil—Dizziness—Furosemide—dilated cardiomyopathy	0.00113	0.00312	CcSEcCtD
Fluorouracil—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00113	0.00312	CcSEcCtD
Fluorouracil—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00112	0.00308	CcSEcCtD
Fluorouracil—UPP2—Metabolism—SDHA—dilated cardiomyopathy	0.00112	0.00759	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—SDHA—dilated cardiomyopathy	0.00112	0.00759	CbGpPWpGaD
Fluorouracil—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00111	0.00306	CcSEcCtD
Fluorouracil—Pain—Lisinopril—dilated cardiomyopathy	0.0011	0.00303	CcSEcCtD
Fluorouracil—Vomiting—Furosemide—dilated cardiomyopathy	0.00109	0.003	CcSEcCtD
Fluorouracil—Rash—Furosemide—dilated cardiomyopathy	0.00108	0.00298	CcSEcCtD
Fluorouracil—Dermatitis—Furosemide—dilated cardiomyopathy	0.00108	0.00297	CcSEcCtD
Fluorouracil—Headache—Furosemide—dilated cardiomyopathy	0.00107	0.00296	CcSEcCtD
Fluorouracil—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00106	0.00292	CcSEcCtD
Fluorouracil—MTHFR—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.00104	0.00704	CbGpPWpGaD
Fluorouracil—Urticaria—Lisinopril—dilated cardiomyopathy	0.00102	0.00281	CcSEcCtD
Fluorouracil—Nausea—Furosemide—dilated cardiomyopathy	0.00102	0.0028	CcSEcCtD
Fluorouracil—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00102	0.0028	CcSEcCtD
Fluorouracil—MTHFR—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.000989	0.00671	CbGpPWpGaD
Fluorouracil—ABCC4—Ectoderm Differentiation—DMD—dilated cardiomyopathy	0.000973	0.00661	CbGpPWpGaD
Fluorouracil—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000947	0.00261	CcSEcCtD
Fluorouracil—SLC22A7—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000934	0.00634	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—ANKRD1—dilated cardiomyopathy	0.000911	0.00618	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—ANKRD1—dilated cardiomyopathy	0.000911	0.00618	CbGpPWpGaD
Fluorouracil—Pruritus—Lisinopril—dilated cardiomyopathy	0.00091	0.00251	CcSEcCtD
Fluorouracil—ALB—Platelet degranulation—TTN—dilated cardiomyopathy	0.000899	0.0061	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.000881	0.00598	CbGpPWpGaD
Fluorouracil—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00088	0.00242	CcSEcCtD
Fluorouracil—DPYD—Metabolism—TAZ—dilated cardiomyopathy	0.000856	0.00581	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—TAZ—dilated cardiomyopathy	0.000856	0.00581	CbGpPWpGaD
Fluorouracil—ALB—Response to elevated platelet cytosolic Ca2+—TTN—dilated cardiomyopathy	0.000856	0.00581	CbGpPWpGaD
Fluorouracil—SLC29A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000856	0.00581	CbGpPWpGaD
Fluorouracil—Dizziness—Lisinopril—dilated cardiomyopathy	0.00085	0.00234	CcSEcCtD
Fluorouracil—TYMS—Nucleotide metabolism—GPX1—dilated cardiomyopathy	0.000844	0.00573	CbGpPWpGaD
Fluorouracil—SLC29A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000833	0.00565	CbGpPWpGaD
Fluorouracil—SLC29A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000833	0.00565	CbGpPWpGaD
Fluorouracil—Vomiting—Lisinopril—dilated cardiomyopathy	0.000818	0.00225	CcSEcCtD
Fluorouracil—Rash—Lisinopril—dilated cardiomyopathy	0.000811	0.00223	CcSEcCtD
Fluorouracil—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00081	0.00223	CcSEcCtD
Fluorouracil—Headache—Lisinopril—dilated cardiomyopathy	0.000806	0.00222	CcSEcCtD
Fluorouracil—ALB—Platelet degranulation—ACTN2—dilated cardiomyopathy	0.000779	0.00529	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—SDHA—dilated cardiomyopathy	0.000775	0.00526	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—SDHA—dilated cardiomyopathy	0.000775	0.00526	CbGpPWpGaD
Fluorouracil—SLC29A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000774	0.00526	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.000764	0.00519	CbGpPWpGaD
Fluorouracil—Nausea—Lisinopril—dilated cardiomyopathy	0.000764	0.0021	CcSEcCtD
Fluorouracil—ALB—Response to elevated platelet cytosolic Ca2+—ACTN2—dilated cardiomyopathy	0.000742	0.00504	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—TUBB—dilated cardiomyopathy	0.000735	0.00499	CbGpPWpGaD
Fluorouracil—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00067	0.00455	CbGpPWpGaD
Fluorouracil—ALB—Platelet degranulation—VCL—dilated cardiomyopathy	0.000663	0.0045	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—TUBB—dilated cardiomyopathy	0.000657	0.00446	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—EMD—dilated cardiomyopathy	0.000655	0.00445	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.00065	0.00441	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—ANKRD1—dilated cardiomyopathy	0.000649	0.00441	CbGpPWpGaD
Fluorouracil—ALB—Response to elevated platelet cytosolic Ca2+—VCL—dilated cardiomyopathy	0.000631	0.00429	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet degranulation—CD36—dilated cardiomyopathy	0.000627	0.00426	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000617	0.00419	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—ALMS1—dilated cardiomyopathy	0.000616	0.00418	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—TAZ—dilated cardiomyopathy	0.00061	0.00414	CbGpPWpGaD
Fluorouracil—MTHFR—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	0.000608	0.00413	CbGpPWpGaD
Fluorouracil—ABCC4—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	0.000597	0.00406	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—EMD—dilated cardiomyopathy	0.000586	0.00398	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00058	0.00394	CbGpPWpGaD
Fluorouracil—ABCC5—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000567	0.00385	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—SDHA—dilated cardiomyopathy	0.000552	0.00375	CbGpPWpGaD
Fluorouracil—ABCC5—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000552	0.00375	CbGpPWpGaD
Fluorouracil—ABCC5—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000552	0.00375	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—ALMS1—dilated cardiomyopathy	0.000551	0.00374	CbGpPWpGaD
Fluorouracil—ABCC5—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000513	0.00348	CbGpPWpGaD
Fluorouracil—MTHFR—Folate Metabolism—TNF—dilated cardiomyopathy	0.000495	0.00336	CbGpPWpGaD
Fluorouracil—SLC22A7—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000488	0.00331	CbGpPWpGaD
Fluorouracil—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—dilated cardiomyopathy	0.000484	0.00329	CbGpPWpGaD
Fluorouracil—SLC22A7—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000475	0.00322	CbGpPWpGaD
Fluorouracil—SLC22A7—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000475	0.00322	CbGpPWpGaD
Fluorouracil—TYMS—Retinoblastoma (RB) in Cancer—RAF1—dilated cardiomyopathy	0.000471	0.0032	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—TTN—dilated cardiomyopathy	0.000454	0.00308	CbGpPWpGaD
Fluorouracil—SLC22A7—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000441	0.003	CbGpPWpGaD
Fluorouracil—ALB—Vitamin B12 Metabolism—SOD2—dilated cardiomyopathy	0.000438	0.00297	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—ANKRD1—dilated cardiomyopathy	0.000428	0.00291	CbGpPWpGaD
Fluorouracil—CYP2C8—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000427	0.0029	CbGpPWpGaD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000418	0.00284	CbGpPWpGaD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000407	0.00276	CbGpPWpGaD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000407	0.00276	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—TAZ—dilated cardiomyopathy	0.000403	0.00273	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.0004	0.00272	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.000399	0.00271	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—ACTN2—dilated cardiomyopathy	0.000394	0.00267	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000393	0.00267	CbGpPWpGaD
Fluorouracil—MTHFR—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000393	0.00267	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—TMPO—dilated cardiomyopathy	0.00039	0.00264	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000386	0.00262	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000382	0.0026	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000382	0.0026	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000379	0.00257	CbGpPWpGaD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000378	0.00257	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—ANKRD1—dilated cardiomyopathy	0.000373	0.00253	CbGpPWpGaD
Fluorouracil—TYMS—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000371	0.00252	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—SDHA—dilated cardiomyopathy	0.000364	0.00247	CbGpPWpGaD
Fluorouracil—ALB—Folate Metabolism—SOD2—dilated cardiomyopathy	0.000356	0.00242	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000356	0.00241	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—TAZ—dilated cardiomyopathy	0.000351	0.00238	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—TMPO—dilated cardiomyopathy	0.000348	0.00236	CbGpPWpGaD
Fluorouracil—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000347	0.00236	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.000346	0.00235	CbGpPWpGaD
Fluorouracil—ALB—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000341	0.00231	CbGpPWpGaD
Fluorouracil—ALB—Folate Metabolism—GPX1—dilated cardiomyopathy	0.00034	0.00231	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—VCL—dilated cardiomyopathy	0.000335	0.00227	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—ANKRD1—dilated cardiomyopathy	0.000332	0.00225	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—GPX1—dilated cardiomyopathy	0.000327	0.00222	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—LMNA—dilated cardiomyopathy	0.00032	0.00217	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—CD36—dilated cardiomyopathy	0.000318	0.00216	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—SDHA—dilated cardiomyopathy	0.000317	0.00215	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—TAZ—dilated cardiomyopathy	0.000312	0.00212	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000309	0.0021	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—GPX1—dilated cardiomyopathy	0.000304	0.00206	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—GPX1—dilated cardiomyopathy	0.000304	0.00206	CbGpPWpGaD
Fluorouracil—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000297	0.00201	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—CD36—dilated cardiomyopathy	0.000296	0.00201	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—CD36—dilated cardiomyopathy	0.000296	0.00201	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.000294	0.002	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000288	0.00196	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—AGT—dilated cardiomyopathy	0.000286	0.00194	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—LMNA—dilated cardiomyopathy	0.000286	0.00194	CbGpPWpGaD
Fluorouracil—ALB—Platelet degranulation—CD36—dilated cardiomyopathy	0.000284	0.00193	CbGpPWpGaD
Fluorouracil—ALB—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000283	0.00192	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—SDHA—dilated cardiomyopathy	0.000282	0.00192	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00028	0.0019	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00028	0.0019	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000278	0.00189	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—ANKRD1—dilated cardiomyopathy	0.000275	0.00187	CbGpPWpGaD
Fluorouracil—ALB—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	0.00027	0.00184	CbGpPWpGaD
Fluorouracil—ALB—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.00027	0.00183	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—AGT—dilated cardiomyopathy	0.000266	0.00181	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—AGT—dilated cardiomyopathy	0.000266	0.00181	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000264	0.00179	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000263	0.00178	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000262	0.00178	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000261	0.00177	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—TAZ—dilated cardiomyopathy	0.000258	0.00175	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000251	0.0017	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000248	0.00169	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000247	0.00168	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—SDHA—dilated cardiomyopathy	0.000234	0.00159	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—NPPA—dilated cardiomyopathy	0.000223	0.00151	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PSEN2—dilated cardiomyopathy	0.000216	0.00146	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000215	0.00146	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—GPX1—dilated cardiomyopathy	0.00021	0.00143	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—GPX1—dilated cardiomyopathy	0.00021	0.00143	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TTN—dilated cardiomyopathy	0.000206	0.0014	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—CD36—dilated cardiomyopathy	0.000205	0.00139	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—CD36—dilated cardiomyopathy	0.000205	0.00139	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000202	0.00137	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—NPPA—dilated cardiomyopathy	0.000194	0.00132	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000193	0.00131	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—ANKRD1—dilated cardiomyopathy	0.00019	0.00129	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PSEN2—dilated cardiomyopathy	0.000188	0.00127	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—AGT—dilated cardiomyopathy	0.000185	0.00125	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—AGT—dilated cardiomyopathy	0.000185	0.00125	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000184	0.00125	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—ACTN2—dilated cardiomyopathy	0.000178	0.00121	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—TAZ—dilated cardiomyopathy	0.000178	0.00121	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000178	0.00121	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000174	0.00118	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000173	0.00117	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000173	0.00117	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000173	0.00117	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ANKRD1—dilated cardiomyopathy	0.000172	0.00117	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000172	0.00117	CbGpPWpGaD
Fluorouracil—SLC29A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000169	0.00115	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—ITGB1—dilated cardiomyopathy	0.000168	0.00114	CbGpPWpGaD
Fluorouracil—ALB—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	0.000166	0.00113	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000164	0.00111	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—TAZ—dilated cardiomyopathy	0.000162	0.0011	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—SDHA—dilated cardiomyopathy	0.000161	0.00109	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000161	0.00109	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—VCL—dilated cardiomyopathy	0.000152	0.00103	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—GPX1—dilated cardiomyopathy	0.00015	0.00102	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—SDHA—dilated cardiomyopathy	0.000146	0.000994	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—CD36—dilated cardiomyopathy	0.000146	0.000991	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—CD36—dilated cardiomyopathy	0.000143	0.000973	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000143	0.000968	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000139	0.000942	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—RAC1—dilated cardiomyopathy	0.000135	0.000917	CbGpPWpGaD
Fluorouracil—ALB—Folate Metabolism—TNF—dilated cardiomyopathy	0.000135	0.000917	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000132	0.000899	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000132	0.000899	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—AGT—dilated cardiomyopathy	0.000131	0.000892	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000126	0.000856	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000126	0.000856	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000126	0.000854	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000125	0.000849	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000119	0.000805	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	0.000118	0.000798	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ANKRD1—dilated cardiomyopathy	0.000117	0.000794	CbGpPWpGaD
Fluorouracil—ABCC5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000112	0.00076	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	0.000111	0.000751	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—TAZ—dilated cardiomyopathy	0.00011	0.000746	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—RAC1—dilated cardiomyopathy	0.000108	0.000736	CbGpPWpGaD
Fluorouracil—ALB—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000107	0.000728	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	0.0001	0.000679	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—SDHA—dilated cardiomyopathy	9.94e-05	0.000675	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—GPX1—dilated cardiomyopathy	9.89e-05	0.000671	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—CD36—dilated cardiomyopathy	9.63e-05	0.000654	CbGpPWpGaD
Fluorouracil—SLC22A7—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.62e-05	0.000653	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	9.57e-05	0.00065	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—RAC1—dilated cardiomyopathy	9.44e-05	0.000641	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	9e-05	0.000611	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—RAF1—dilated cardiomyopathy	8.96e-05	0.000608	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—AGT—dilated cardiomyopathy	8.67e-05	0.000589	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—GPX1—dilated cardiomyopathy	8.61e-05	0.000585	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—CD36—dilated cardiomyopathy	8.39e-05	0.000569	CbGpPWpGaD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	8.25e-05	0.00056	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	8.18e-05	0.000555	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	8.14e-05	0.000552	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	7.86e-05	0.000534	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	7.76e-05	0.000526	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	7.69e-05	0.000522	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—GPX1—dilated cardiomyopathy	7.67e-05	0.000521	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—ITGB1—dilated cardiomyopathy	7.61e-05	0.000516	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—AGT—dilated cardiomyopathy	7.55e-05	0.000513	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—CD36—dilated cardiomyopathy	7.47e-05	0.000507	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—RAF1—dilated cardiomyopathy	7.19e-05	0.000488	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	6.95e-05	0.000472	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—AGT—dilated cardiomyopathy	6.73e-05	0.000457	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—CD36—dilated cardiomyopathy	6.49e-05	0.00044	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—GPX1—dilated cardiomyopathy	6.35e-05	0.000431	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—RAF1—dilated cardiomyopathy	6.26e-05	0.000425	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—CD36—dilated cardiomyopathy	6.18e-05	0.00042	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—RAC1—dilated cardiomyopathy	6.11e-05	0.000415	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	6.1e-05	0.000414	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	6.06e-05	0.000412	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.94e-05	0.000403	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.91e-05	0.000401	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.69e-05	0.000386	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—AGT—dilated cardiomyopathy	5.57e-05	0.000378	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.35e-05	0.000363	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.32e-05	0.000361	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.96e-05	0.000337	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—EGFR—dilated cardiomyopathy	4.93e-05	0.000335	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.83e-05	0.000328	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—GPX1—dilated cardiomyopathy	4.38e-05	0.000297	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.35e-05	0.000295	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—EGFR—dilated cardiomyopathy	4.29e-05	0.000291	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CD36—dilated cardiomyopathy	4.26e-05	0.000289	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.24e-05	0.000288	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.13e-05	0.00028	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—RAF1—dilated cardiomyopathy	4.05e-05	0.000275	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GPX1—dilated cardiomyopathy	3.98e-05	0.00027	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CD36—dilated cardiomyopathy	3.87e-05	0.000263	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—AGT—dilated cardiomyopathy	3.84e-05	0.000261	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.72e-05	0.000253	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.51e-05	0.000238	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—AGT—dilated cardiomyopathy	3.49e-05	0.000237	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	2.72e-05	0.000184	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GPX1—dilated cardiomyopathy	2.7e-05	0.000183	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	2.65e-05	0.00018	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CD36—dilated cardiomyopathy	2.63e-05	0.000179	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	2.38e-05	0.000162	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—AGT—dilated cardiomyopathy	2.37e-05	0.000161	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	2.21e-05	0.00015	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	2.15e-05	0.000146	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	1.94e-05	0.000132	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	1.89e-05	0.000128	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	1.84e-05	0.000125	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	1.66e-05	0.000112	CbGpPWpGaD
